Urogen Pharma Ltd (NASDAQ:URGN)

5.65
Delayed Data
As of May 20
 +0.14 / +2.54%
Today’s Change
5.25
Today|||52-Week Range
19.66
-40.59%
Year-to-Date

Today’s Trading

Previous close5.51
Today’s open5.41
Day’s range5.25 - 5.65
Volume5,702
Average volume (3 months)142,289
Market cap$137.5M
Data as of 4:04pm ET, 05/20/2022

Growth & Valuation

Earnings growth (last year)+15.93%
Earnings growth (this year)+9.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+307.17%
P/E ratioNM
Price/Sales4.42
Price/Book16.18

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.11-3.15%
INMBINmune Bio Inc-0.07-0.94%
NMTR9 Meters Biopharma I...+0.04+9.49%
PIRSPieris Pharmaceutica...+0.01+0.56%
Data as of 4:05pm ET, 05/20/2022

Financials

Next reporting dateAugust 15, 2022
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$48.0M
Annual profit (last year)-$110.8M
Net profit margin-230.67%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Princeton, New Jersey

Forecasts